Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Sen. Biden bill proposes to require government purchase of cocaine, heroin addiction treatments.

Executive Summary

SEN. BIDEN's ANTI-ADDICTION RESEARCH BILL would require the federal government to purchase patent rights to the first successful pharmaceutical treatments for cocaine and heroin addiction. Legislation (S 2051) introduced Sept. 3 by Sen. Biden (D-Del.), the ranking minority member of the Senate Judiciary Committee, would set into law the price tag for these patents: $100 mil. for a drug to treat cocaine addiction and $50 mil. for a heroin treatment.

Latest Headlines
See All
UsernamePublicRestriction

Register

PS028834

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel